Mereo Biopharma
MREO
Mereo Biopharma (MREO) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Downgraded | Neutral → Underweight | — | Aug 19, 2026 |
| BTIG | Maintained | Buy | $1.00 | Aug 11, 2026 |
| Needham | Maintained | Buy | $3.00 | Aug 11, 2026 |
| BTIG | Maintained | Buy | $1.00 | May 12, 2026 |
| JP Morgan | Downgraded | Overweight → Neutral | — | Mar 23, 2026 |
| BTIG | Maintained | Buy | $1.00 | Jan 16, 2026 |
| Needham | Maintained | Buy | $3.00 from $5.00 | Jan 13, 2026 |
| Jefferies | Downgraded | Buy → Hold | $0.50 from $7.00 | Dec 30, 2025 |
| BTIG | Maintained | Buy | $1.00 from $6.00 | Dec 29, 2025 |
| LifeSci Capital | Downgraded | Outperform → Market Perform | — | Dec 29, 2025 |
| Needham | Maintained | Buy | $5.00 | Dec 22, 2025 |
| BTIG | Maintained | Buy | $6.00 | Dec 18, 2025 |
| JP Morgan | Maintained | Overweight | $8.00 from $7.00 | Aug 25, 2025 |
| Needham | Maintained | Buy | $5.00 from $7.00 | Jul 10, 2025 |
| Needham | Maintained | Buy | $7.00 | May 13, 2025 |
| Needham | Maintained | Buy | $7.00 | Apr 9, 2025 |
| JP Morgan | Initiated Coverage | Overweight | $7.00 | Mar 27, 2025 |
| Needham | Maintained | Buy | $7.00 | Mar 26, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | $7.00 | Mar 18, 2025 |
| Needham | Maintained | Buy | $7.00 | Jan 13, 2025 |
Frequently asked questions
What is the latest analyst rating on MREO?
On Aug 19, 2026, JP Morgan downgraded Mereo Biopharma to Underweight.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.